Regulated information - inside information
Breda, the Netherlands / Ghent, Belgium, May 16, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of diff [...]
Munich, Germany — May 11, 2017 — LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series A Round of Cardior Pharmaceuticals, a private German company develo [...]
Regulated information - inside information
Breda, the Netherlands / Ghent, Belgium, May 8, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of diffe [...]
Successful exit after 1,5 years validates LSPs investment rationale
Munich, Germany ─ May 8, 2017 ─ LSP today announced that it has sold its portfolio company Luxendo, a spin-off of the European Molecul [...]
Top-line data from the study expected in first quarter of 2018
Breda, the Netherlands / Ghent, Belgium, May 4, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a dee [...]
Amsterdam, the Netherlands — May 3, 2017 — LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series A Round of Imcheck Therapeutics, a private French company [...]
Breda, the Netherlands/Ghent, Belgium, May 2, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment o [...]
Amsterdam, The Netherlands, April 26, 2017 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative pro [...]
In a release issued April 28, 2017 by Merus N.V. (Nasdaq:MRUS) with the same headline, an error was made such that the figures for the three months ended December 31, 2016 in the “Consolidated Statement of Profit or [...]
Several ECCMID 2017 presentations highlight advantages of rapid time to result with Unyvero ITI in Prosthetic Joint Infections
Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 27, 2017 - C [...]
Regulated information - inside information
Breda, the Netherlands / Ghent, Belgium, May 16, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of diff [...]
Munich, Germany — May 11, 2017 — LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series A Round of Cardior Pharmaceuticals, a private German company develo [...]
Regulated information - inside information
Breda, the Netherlands / Ghent, Belgium, May 8, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of diffe [...]
Successful exit after 1,5 years validates LSPs investment rationale
Munich, Germany ─ May 8, 2017 ─ LSP today announced that it has sold its portfolio company Luxendo, a spin-off of the European Molecul [...]
Top-line data from the study expected in first quarter of 2018
Breda, the Netherlands / Ghent, Belgium, May 4, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a dee [...]
Amsterdam, the Netherlands — May 3, 2017 — LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series A Round of Imcheck Therapeutics, a private French company [...]
Breda, the Netherlands/Ghent, Belgium, May 2, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment o [...]
Amsterdam, The Netherlands, April 26, 2017 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative pro [...]
In a release issued April 28, 2017 by Merus N.V. (Nasdaq:MRUS) with the same headline, an error was made such that the figures for the three months ended December 31, 2016 in the “Consolidated Statement of Profit or [...]
Several ECCMID 2017 presentations highlight advantages of rapid time to result with Unyvero ITI in Prosthetic Joint Infections
Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 27, 2017 - C [...]
Follow us
